News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Equipo de GENESIS
GENESIS Biomed consolidates its growth in the biomedical sector
Healthcare
The consultancy firm GENESIS Biomed, a national reference in advisory services for early-stage…
Partners - Parc Científic de Barcelona
Sergio_Escorza_Treviño
#NewAseBioAlly | "AseBio is a gateway, a meeting point with and for companies, associations, foundations, universities, technology and research centers that carry out activities in the field of biotechnology"
Corporate
Meet UNGRIA Patentes y Marcas, our new ally. We talked with Sergio Escorza…
Premio Proyecto Emprendedor de Innova Health 2023 a Peaches
Peaches Biotech receives the Innova Health 2023 Award for the most innovative project
Healthcare · Innovative drugs · Personalized medicine · Advanced therapies
It is a recognition of the company, its professionals and the advances achieved in its secretome-…
Partners - PEACHES BIOTECH S.L.
BIOSPAIN_2023
The 94% of BIOSPAIN 2023 attendees positively evaluate the event
BioSpain
The satisfaction survey highlights significant findings, such as the positive assessment of the…
Laboratorio biotecnología AseBio
Science and Innovation, the Pending Subject of Spain and a Weak Point in the Progress towards Strategic Autonomy
Healthcare · Access to innovation · Climate change · Agrifood · Industrial biotechnology · Financing · Talento
Spain needs a clear regulatory framework and support for the biotechnological industry with long-…
Biotecnología_edición_genética_plantas
The European Parliament's Committee on Environment, Public Health and Food Safety advocates allowing the use of NGTs in organic agriculture
Agrifood · Food & feed · Agriculture
The ENVI Committee of the European Parliament advocates expanding the category 1 of NGTs, allowing…
oryzon-biotech-asebio
ORYZON announces Last Patient Last Visit in its Phase IIb PORTICO study for Borderline Personality Disorder (BPD)
Healthcare · Access to innovation · Innovative drugs
Multiple primary endpoints include reduction in agitation and aggression and overall BPD…
Partners - Oryzon Genomics
ysioscapital-biotech-asebio
Kynexis Launched to Advance Precision Therapeutics for Brain Diseases
Healthcare · Access to innovation
Lead candidate KYN-5356, a first-in-class small Molecule KAT-II inhibitor advancing toward the…
Partners - Ysios Capital Partners
Oryzon-Asebio-Biotecnologia
ORYZON to provide corporate progress updates at several events in november
Corporate
Oryzon’s CEO, Dr. Carlos Buesa, will attend the LSX Investival Showcase, to be held on November 13…
Partners - Oryzon Genomics